Advanced Health Intelligence Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AHI research report →
Price Chart
About the company
Advanced Health Intelligence Ltd is an Australian company with global operations, specializing in the creation of mobile applications and technological platforms. The firm owns and patents BodyScan, its unique measurement technology that empowers users to assess their body dimensions using a smartphone. Additionally, it provides FaceScan, which is engineered for measuring vital signs and evaluating the risks associated with cardiovascular disease, heart attacks, and strokes, as well as DermaScan, a specialized dermatological scanning device.
- CEO
- Scott Montgomery
- IPO
- 2021
- Employees
- 32
- HQ
- South Perth, WA, AU
Get TickerSpark's AI analysis on AHI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $345.76M
- P/E
- -5.64
- PEG
- -0.06
- P/S
- 9.24
- P/B
- 13.38
- EV/EBITDA
- -8.78
- Div Yield
- 0.00%
- Gross Margin
- -138.90%
- Op Margin
- -137.47%
- Net Margin
- -154.66%
- ROE
- -219.41%
- ROIC
- -57.38%
Latest fiscal year · YoY change
- Revenue
- $368.43K-43.7%
- Gross Profit
- $0+100.0%
- Op Income
- $-7,408,640
- Net Income
- $-4,147,394+67.7%
- EPS
- $-0.56+71.3%
- OCF Growth
- +35.6%
- FCF Growth
- +36.1%
- 52W High
- $1.50
- 52W Low
- $1.50
- 50D MA
- $1.50
- 200D MA
- $1.50
- Beta
- 1.61
- RSI (14)
- 31
- Avg Volume
- 0
No earnings-call transcripts are available for AHI yet.
- Free Float
- 75.0%
- Shares Outstanding
- 8.23M
- Float Shares
- 6.17M
of shares held by institutions
7 13F filers
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 17, 03 | BANNISTER DAVID G/ | other | 5,000 |
| Sep 17, 03 | STRANGE J LELAND | other | 5,000 |
| Sep 17, 03 | BENTON WILLIAM P | other | 5,000 |
| Sep 17, 03 | BANNISTER DAVID G/ | other | 5,000 |
| Sep 17, 03 | BENTON WILLIAM P | other | 5,000 |
| Sep 17, 03 | STRANGE J LELAND | other | 5,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AHI coverage
Recent articles, reports, and earnings notes.
No research on AHI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AHI report →Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X
globenewswire.com · Aug 25
Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and i
gurufocus.com · Jun 6
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
globenewswire.com · Sep 27
Advanced Health Intelligence CEO to Deliver Investor Presentation in Atlantic City
newsfilecorp.com · Jan 18
Advanced Health Intelligence Signs Binding Term Sheet with Electronic Medical Record and Global Personal Health Record Company OneClinic for Vietnam
newsfilecorp.com · Nov 3
Dr. Walid Abbas Zaher Honored as a Top Healthcare Leader by Forbes Middle East
newsfilecorp.com · Oct 19
Advanced Health Intelligence to provide Biometric Health Screening in new Collaboration between Bearn and OnCore Innovations Inc.
newsfilecorp.com · Oct 9
Advanced Health Intelligence Issues a Retraction
newsfilecorp.com · Sep 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.